Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1046/j.1469-0691.2000.00063.x http://repositorio.unifesp.br/handle/11600/26275 |
Resumo: | Objective To assess the susceptibility of the : key respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.Methods isolates were collected from five centers in Brazil during 1997-98, and susceptibility testing was conducted at a central laboratory according to National Committee for Clinical Laboratory Standards criteria.Results of the 359 Streptococcus pneumoniae isolates tested, 77% were susceptible, 19% were intermediate and 4% were resistant to penicillin. the susceptibility of S. pneumoniae to other beta-lactams and macrolides was greater than 90%, but cotrimoxazole was active against only 48% of the: isolates, the prevalence of susceptible isolates was 100.0% for vancomycin and 99.7% for levofloxacin. beta-Lactram, macrolide, and cotrimoxazole activities were negatively associated with penicillin resistance. of the 219 isolates of Haemophilus influenzae tested, 11% produced beta-lactamase and 11% were not susceptible to ampicillin. Nearly all H. influenzae isolates were susceptible to all other drugs, except cotrimoxazole (47% susceptibility). of the 52 Moraxella catarrhalis isolates, 98% produced beta-lactamase, and the MIC of all drugs was less than or equal to 4 mg/L, with the exception of amyicillin, where the: MIC90 was > 8 mg/L.Conclusions When these data are compared with previous reports, our findings suggest that the prevalence of pneumococci that are resistant to agents such as penicillin and cotrimoxazole may be increasing in Brazil, which highlights the need to continue surveillance programs. |
id |
UFSP_b351860abc33274ca934f09340a90a90 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/26275 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98Streptococcus pneumoniaeantibiotic resistancesurveillanceObjective To assess the susceptibility of the : key respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.Methods isolates were collected from five centers in Brazil during 1997-98, and susceptibility testing was conducted at a central laboratory according to National Committee for Clinical Laboratory Standards criteria.Results of the 359 Streptococcus pneumoniae isolates tested, 77% were susceptible, 19% were intermediate and 4% were resistant to penicillin. the susceptibility of S. pneumoniae to other beta-lactams and macrolides was greater than 90%, but cotrimoxazole was active against only 48% of the: isolates, the prevalence of susceptible isolates was 100.0% for vancomycin and 99.7% for levofloxacin. beta-Lactram, macrolide, and cotrimoxazole activities were negatively associated with penicillin resistance. of the 219 isolates of Haemophilus influenzae tested, 11% produced beta-lactamase and 11% were not susceptible to ampicillin. Nearly all H. influenzae isolates were susceptible to all other drugs, except cotrimoxazole (47% susceptibility). of the 52 Moraxella catarrhalis isolates, 98% produced beta-lactamase, and the MIC of all drugs was less than or equal to 4 mg/L, with the exception of amyicillin, where the: MIC90 was > 8 mg/L.Conclusions When these data are compared with previous reports, our findings suggest that the prevalence of pneumococci that are resistant to agents such as penicillin and cotrimoxazole may be increasing in Brazil, which highlights the need to continue surveillance programs.MRL, Pharmaceut Serv, Herndon, VA 20171 USAMRL Pharmaceut Serv, Brentwood, TN USAMRL Pharmaceut Serv, Utrecht, NetherlandsHosp Clin Porto Alegre, Porto Alegre, RS, BrazilHosp Clin São Paulo, Lab Fleury, São Paulo, BrazilUniversidade Federal de São Paulo, São Paulo, BrazilUniv Fed Rio de Janeiro, Rio de Janeiro, BrazilUniversidade Federal de São Paulo, São Paulo, BrazilWeb of ScienceBlackwell Science LtdMRLMRL Pharmaceut ServHosp Clin Porto AlegreUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)Universidade Federal do Rio de Janeiro (UFRJ)Critchley, I. A.Thornsberry, C.Piazza, G.Jones, M.Hickey, M. L.Barth, A. L.Mendes, C.Rossi, F. F.Sader, Helio Silva [UNIFESP]Teixeira, L. M.Sahm, D. F.2016-01-24T12:31:02Z2016-01-24T12:31:02Z2000-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion178-184http://dx.doi.org/10.1046/j.1469-0691.2000.00063.xClinical Microbiology and Infection. Oxford: Blackwell Science Ltd, v. 6, n. 4, p. 178-184, 2000.10.1046/j.1469-0691.2000.00063.x1198-743Xhttp://repositorio.unifesp.br/handle/11600/26275WOS:000086961300002engClinical Microbiology and Infectioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:31:02Zoai:repositorio.unifesp.br/:11600/26275Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:31:02Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 |
title |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 |
spellingShingle |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 Critchley, I. A. Streptococcus pneumoniae antibiotic resistance surveillance |
title_short |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 |
title_full |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 |
title_fullStr |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 |
title_full_unstemmed |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 |
title_sort |
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98 |
author |
Critchley, I. A. |
author_facet |
Critchley, I. A. Thornsberry, C. Piazza, G. Jones, M. Hickey, M. L. Barth, A. L. Mendes, C. Rossi, F. F. Sader, Helio Silva [UNIFESP] Teixeira, L. M. Sahm, D. F. |
author_role |
author |
author2 |
Thornsberry, C. Piazza, G. Jones, M. Hickey, M. L. Barth, A. L. Mendes, C. Rossi, F. F. Sader, Helio Silva [UNIFESP] Teixeira, L. M. Sahm, D. F. |
author2_role |
author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
MRL MRL Pharmaceut Serv Hosp Clin Porto Alegre Universidade de São Paulo (USP) Universidade Federal de São Paulo (UNIFESP) Universidade Federal do Rio de Janeiro (UFRJ) |
dc.contributor.author.fl_str_mv |
Critchley, I. A. Thornsberry, C. Piazza, G. Jones, M. Hickey, M. L. Barth, A. L. Mendes, C. Rossi, F. F. Sader, Helio Silva [UNIFESP] Teixeira, L. M. Sahm, D. F. |
dc.subject.por.fl_str_mv |
Streptococcus pneumoniae antibiotic resistance surveillance |
topic |
Streptococcus pneumoniae antibiotic resistance surveillance |
description |
Objective To assess the susceptibility of the : key respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.Methods isolates were collected from five centers in Brazil during 1997-98, and susceptibility testing was conducted at a central laboratory according to National Committee for Clinical Laboratory Standards criteria.Results of the 359 Streptococcus pneumoniae isolates tested, 77% were susceptible, 19% were intermediate and 4% were resistant to penicillin. the susceptibility of S. pneumoniae to other beta-lactams and macrolides was greater than 90%, but cotrimoxazole was active against only 48% of the: isolates, the prevalence of susceptible isolates was 100.0% for vancomycin and 99.7% for levofloxacin. beta-Lactram, macrolide, and cotrimoxazole activities were negatively associated with penicillin resistance. of the 219 isolates of Haemophilus influenzae tested, 11% produced beta-lactamase and 11% were not susceptible to ampicillin. Nearly all H. influenzae isolates were susceptible to all other drugs, except cotrimoxazole (47% susceptibility). of the 52 Moraxella catarrhalis isolates, 98% produced beta-lactamase, and the MIC of all drugs was less than or equal to 4 mg/L, with the exception of amyicillin, where the: MIC90 was > 8 mg/L.Conclusions When these data are compared with previous reports, our findings suggest that the prevalence of pneumococci that are resistant to agents such as penicillin and cotrimoxazole may be increasing in Brazil, which highlights the need to continue surveillance programs. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-04-01 2016-01-24T12:31:02Z 2016-01-24T12:31:02Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1046/j.1469-0691.2000.00063.x Clinical Microbiology and Infection. Oxford: Blackwell Science Ltd, v. 6, n. 4, p. 178-184, 2000. 10.1046/j.1469-0691.2000.00063.x 1198-743X http://repositorio.unifesp.br/handle/11600/26275 WOS:000086961300002 |
url |
http://dx.doi.org/10.1046/j.1469-0691.2000.00063.x http://repositorio.unifesp.br/handle/11600/26275 |
identifier_str_mv |
Clinical Microbiology and Infection. Oxford: Blackwell Science Ltd, v. 6, n. 4, p. 178-184, 2000. 10.1046/j.1469-0691.2000.00063.x 1198-743X WOS:000086961300002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Clinical Microbiology and Infection |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
178-184 |
dc.publisher.none.fl_str_mv |
Blackwell Science Ltd |
publisher.none.fl_str_mv |
Blackwell Science Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268352046039040 |